Main > NEUROLOGY. > Stroke. Treatment > Stem Cell. > Mammal Neural Stem Cells. > Patent > Claims > Claim 1: Mammal Cognitive Deficit > Caused by Brain Damage Treat.: > Adm. PluriPotent Cells into > Damaged Mammalian Brain, Wherein > Damage is Mainly in One Hemisphere > & Said Adm. is in Brain Hemisphere > Contra-Lateral to Brain Hemisphere > Contg. the Main Site of Damage > Wherein PluriPotent Cells are: > Hippocampal Mouse Cells Comprising > Gene Encoding the tsA58 Mutant > of the SV40 Large T Antigen under > Control of H-2Kb Promoter; Wherein > Cells Differentiate in Neural Cell > Claim 2: Brain Damage. Stroke. > Claims 3,4: PluriPotent Cells are: > NeuroEpithelial Stem Cells & > MHP36 Clonal Cell Line resp. > Claim 10: IntraParenchymal Adm. > Claim 15: PluriPotent Cells Derived > H-2Kb-tsA58 TransGenic Mouse. > Patent Assignee
Patent Assignee's products
UK. R